New research showing that sudden cardiac death strikes one in 5,200 males in Division I basketball is likely to intensify one of the hottest debates in college sports: Should NCAA athletes undergo electrical cardiac screening?
Lawsuits advancing in federal court in Alabama allege that the 37 independently owned Blue Cross and Blue Shield health insurers, which cover about a third of Americans, are functioning as an illegal cartel.
Six new proton-beam centers are set to start delivering state-of-the-art radiation to U.S. cancer patients in coming months. The projects—many costing between $25 million and $30 million—will enter an uncertain market.
Critics question whether legislation aimed at boosting medical research funding and revamping rules over drug and device safety would open the way for companies to sell drugs and devices that aren’t fully tested.